WHWK (Aadi Bio) Pangali Forward P/E
The exclusivity of its rare tumor therapy allows Aadi Bioscience Inc (WHWK) to maintain premium pricing power. The company's forward P/E ratio clearly demonstrates the market's reaction to this potential, where 0.00 reflects the current value of this metric. Well-established cold chain logistics and management's experience in bringing Fyarro to market under strict cost controls support the business's stability.
Ringkesan rincian data analitis Aadi Bio (WHWK)
- rega saiki lan proyeksi nilai saham:
- indikator valuasi pasar bisnis:
- informasi kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Aadi Bioscience Inc|WHWK - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Aadi Bioscience Inc|WHWK - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Aadi Bioscience, Inc.|WHWK - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aadi Bioscience|Rasio cepet aadibio.com
- rincian asil keuangan lan kelipatan valuasi:
WHWK - Asil keuangan resik|Bathi mangsa ngarep Aadi Bioscience Inc|WHWK - Nilai perusahaan marang bathi resik|Pangali Forward P/E Aadi Bioscience Inc|WHWK - Rasio rega marang bathi tumrap wutah|Pangali EV/EBITDA Aadi Bioscience, Inc.|WHWK - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Aadi Bioscience|WHWK - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan aadibio.com|WHWK - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Aadi Bioscience Inc
Analisis komprehensif perusahaan:Aadi Bioscience
Investors are assessing the potential of Aadi Bioscience Inc (WHWK) through the capital payback period, calculated as the ratio of the current market share price to the projected earnings per share. By analyzing the changes in the company's expected P/E ratio, one can determine to what extent the monopoly on orphan drugs and patent protection justify the current business valuation in an environment of expensive debt capital.
Analisis perusahaan pesaing
Prakiraan rega marang bathi ONC (BeiGene)|HALO (Halozyme Therapeutics, Inc.) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E RVMD (RevMed)|AAPG - Prakiraan rega marang bathi|CGON: Prakiraan rega marang bathi|URGN - Pangali Forward P/E|Bicara Therapeutics (BCAX) - Rega marang bathi mangsa ngarep|Personalis Inc - Pangali mangsa ngarep rega marang bathi|ERAS (Erasca Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Delcath Corp DCTH|Pangali Forward P/E YMAB|Pangali Forward P/E aurabiosciences.com (AURA)|Pangali Forward P/E CADL (Candel Therapeutics, Inc.)|Pangali Forward P/E Accuray Inc ARAY|SELLAS Life Sciences Group Inc. - Pangali Forward P/E|ACTU (Actuate Therapeutics Inc) - Rasio rega marang bathi mangsa ngarep|CTOR: Pangali Forward P/E|HURA - Kapitalisasi marang proyeksi bathi|Prakiraan rega marang bathi TARA|FATE: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TCRX|Rega marang bathi mangsa ngarep CSBR (championsoncology.com)|Pangali Forward P/E XBIT (XBiotech)|Kapitalisasi marang proyeksi bathi CEL-SCI Corp. (CVM)|OSTX - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi radiopharmtheranostics.com|artivabio.com (ARTV) - Rega marang bathi mangsa ngarep|ANL - Kapitalisasi marang proyeksi bathi|VERU (Veru Inc.) - Pangali Forward P/E|Prakiraan rega marang bathi tempesttx.com (TPST)|Pangali Forward P/E XLO|Kapitalisasi marang proyeksi bathi renovarobio.com|Pangali Forward P/E MURA (Mural Oncology)|Kairos Pharma Limited (KAPA) - Rasio prakiraan rega marang bathi|OKUR - Rega marang bathi mangsa ngarep|GDTC (CytoMed Therapeutics) - Rasio rega marang bathi mangsa ngarep|CRIS: Pangali Forward P/E|Prakiraan rega marang bathi Apollomics|THAR (Tharimmune Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Advanced Biomed Corp ADVB|Prakiraan rega marang bathi GNPX (Genprex, Inc.)|CLDI (calidibio.com) - Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E SBFM (Sunshine Biopharma, Inc.)|Kapitalisasi marang proyeksi bathi Xenetic Biosciences Inc. (XBIO)|SLRX - Rega marang bathi mangsa ngarep|PPBT (Kitov Pharma) - Rasio rega marang bathi mangsa ngarep|AONC: Pangali Forward P/E|Prakiraan rega marang bathi beigene.com|Prakiraan rega marang bathi CKPT|Prakiraan rega marang bathi elevationoncology.com (ELEV)|Pangali Forward P/E ICAD|IKNA (ikenaoncology.com) - Pangali mangsa ngarep rega marang bathi|Notable Labs, Ltd. - Prakiraan rega marang bathi|VIRX - Prakiraan rega marang bathi|MOR - Rega marang bathi mangsa ngarep|NAYA - Pangali Forward P/E|AAPGV: Pangali Forward P/E
